Navigation Links
EntreMed Will Not Seek Shareholder Approval for Reverse Stock Split at Annual Meeting
Date:4/22/2008

ROCKVILLE, Md., April 22 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that the Company's Board of Directors has decided against seeking stockholder approval for a reverse stock split at the Annual Meeting of Stockholders to be held on June 5, 2008. In light of recent gains in the Company's stock price, management's confidence in the Company's product candidate pipeline and the Company's current cash position, the Board of Directors concluded that it is not necessary to seek stockholder approval of a reverse stock split at this time.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

On April 4, 2008, the Company issued a press release disclosing that it had received a Deficiency Notice from the Listing Qualifications Department of the NASDAQ Stock Market, LLC, and had announced its intention to seek stockholder approval for a reverse stock split. The Company remains committed to becoming compliant with all Nasdaq listing requirements.

About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company developing therapeutic candidates primarily for the treatment of cancer and inflammation.

MKC-1 is currently in multiple Phase 2 clinical trials for cancer. MKC-1 is an oral cell-cycle regulator with activity against the mTOR pathway. ENMD-1198, a novel antimitotic agent, and ENMD-2076, a selective kinase inhibitor, are in Phase 1 studies in advanced cancers. The Company also has an approved IND application for Panzem(R) in rheumatoid arthritis. EntreMed's goal is t
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. EntreMeds Kinase Inhibitor, ENMD-2076, Presented During AACR Special Session
2. EntreMed Receives Nasdaq Deficiency Notice
3. EntreMed to Present at BioCentury Future Leaders in the Biotech Industry Conference
4. EntreMed Announces 2008 Corporate and Clinical Program Priorities
5. EntreMed Reports Fourth Quarter and Year-End 2007 Financial Results
6. EntreMed to Present at BIO CEO and Investor Conference
7. EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study
8. EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
9. EntreMed Appoints Senior Vice President of Research and Development
10. EntreMed to Present at ThinkEquity Partners 5th Annual Growth Conference
11. Glass Lewis & Co. Recommends Renovis Shareholders Vote For Merger With Evotec

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2009)...E, Mass., Nov. 7, Research project...red top marks this evening, as Tim Kunisky of Livi...(Jack) Chen of Audubon, PA received the highest ho... Competition in Math, Science & Technology, th.... ,, ( http://www.newscom.com/cgi-bin/prnh/200...
(Date:11/6/2009)..., N.Y., Nov. 6 BioSpecif...maceutical company developing first-in-class colla...al results for the third quarter ended September 3...September of this year, the FDA,s Arthritis Adviso... 12-0, the approval of XIAFLEX(TM) for the treatme...
(Date:11/6/2009)...Mass., Nov. 6 Myriant Technologies...per and manufacturer of renewable bio-chemicals, ...nology provider Uhde GmbH, one of the world,s lead...unced an alliance for the engineering, procurement...ccinic Acid plants based on renewable feedstocks. ...
(Date:11/6/2009)...O, Calif., Nov. 6 ,,...ransfer of Qutenza(TM) E.U. Marketing Authorizatio...t progress in commercial readiness activities Exp...Director, Marketing; and Director, Commercial Oper...director and Audit Committee chairman , Upc...
Breaking Biology Technology:Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 3Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 4Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 5Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 6Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10
....S. Patent and Trade Office issued U.S. Patent No....lymerase and Uses Thereof to the Wisconsin Alumni...y of the University of Wisconsin-Madison. ConjuGo...lectual property invented by its co-founder Richar...research group, which included ConjuGon scientist ...
...le System was chosen by Popular Science magazine ..., ,To be among the 100 selected by Popular Science...chnology must represent a significant step forward...ble System features In-Cell Charge Control (I-C3)t... the battery, instead of the charger. This breakt...
...built the supply chain industries first fully func...adio frequency identification (RFID) laboratory d...vironment. The RFID Lab is enabling RedPrairie cus...t and readability as they prepare for RFID complia...scenarios, the RFID Lab is helping companies deter...
Other Biology Technology:RedPrairie Builds RFID Lab - Enables Real-World Testing 2
(Date:11/9/2009)... LAS VEGAS, Nov. 9 CBS Vision, the...gency OMD, an Omnicom Media Group company, today a...w OMD,s clients access to the CBS Television City ... Las Vegas. ,, The new venture, which marries ...nty,s leading agencies, will be called Communicati...
(Date:11/9/2009)..., N.Y. Oncologists have had their hands tied beca...ions that disable a protein called p53. As a criti...cancer-fighting operations within cells. When cell...not be treated. , These tumors might be tough, ...rom Cold Spring Harbor Laboratory (CSHL). The chin...
(Date:11/9/2009)...f butterfly wings has inspired a 3.2m, three-year ...on in the fields of security, energy and the envir... technology company QinetiQ have just signed a col...sed on groundbreaking physical sciences research. ...s from the University of Exeter and QinetiQ will w...
Breaking Biology News(10 mins):CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 2CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 3CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 4CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2Finances Trigger American Reluctance to Spend More on Healthier Foods 49018 1Finances Trigger American Reluctance to Spend More on Healthier Foods 49018 2Despite Generic Erosion of Key Brands the Hospital Acquired Gram Negative Infections Drug Market Will Increase by 241 Billion from 2008 to 2018 49015 1Despite Generic Erosion of Key Brands the Hospital Acquired Gram Negative Infections Drug Market Will Increase by 241 Billion from 2008 to 2018 49015 2Despite Generic Erosion of Key Brands the Hospital Acquired Gram Negative Infections Drug Market Will Increase by 241 Billion from 2008 to 2018 49015 3AirClic Mobile Business Solutions Clic for Bio Reference Laboratories Inc 49012 1AirClic Mobile Business Solutions Clic for Bio Reference Laboratories Inc 49012 2
...e that provides resistance to a fungal disease res...eld has been discovered by scientists from the US ...g more durable resistance to a devastating disease...he report, recently appointed to the John Innes Ce...previously been achieved using genes that are spec...
..., Virginia (Feb. 20, 2009) In a startling result,...Conservation Biology found that more than 80 perc...-2000 occurred in regions identified as the most b.... , Titled "Warfare in Biodiversity Hotspots," th...ntists compared major conflict zones with the Eart...
...rs at Uppsala University can now show that what is... sex. In fact, evolutionary conflicts between the...t are downright injurious to the opposite sex. Th...ournal Current Biology . , In both males and fem...ommon that one might like to think for one sex to...
Other Biology News:Gene to reduce wheat yield losses 2Study finds most wars occur in Earth's richest biological regions 2Study finds most wars occur in Earth's richest biological regions 3Mating that causes injuries 2
Bovine IgG2 ELISA Kit from Bethyl Laboratories
Dog IgE ELISA Kit from Bethyl Laboratories
PCP ELISA Kit, Single from Bio-Quant Inc.
...Protocol Development ,Antibody Titer and Optimal C...or Human Cells and Tissues ,Double Antibody Labeli...phatase, Immunogold, and Fluorescent detection ,Li...Localization in Transgenic Animals ,Hundreds of Sp...
Biology Products: